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1. Introduction 
Currently, most of the time spent caring for the patients with permanent pacemaker will be 
concerned with evaluating the function of the previously implanted pacing system. Pacing 
system malfunction can be secondary to pacemaker circuitry failure or to lead dysfunction. 
Various tools are available to help evaluation of the pacing system malfunction, including 
physical examination, standard 12-lead ECG, ambulatory ECG monitoring, stored telemetry 
data, chest x-ray, and fluoroscopy. 
This chapter will discuss the differential diagnosis, evaluation, and management of the 
common malfunctions encountered in the single-chamber, dual-chamber, and biventricular 
pacing system. 
2. Single-chamber pacing system malfunction 
Although many pacing system malfunction are common to single-chamber and dual-
chamber devices, the latter are more challenging. This section will discuss the common 
malfunctions associated with single-chamber pacing systems. The subsequent sections will 
focus on specific abnormalities associated with dual-chamber and biventricular pacing 
systems. 
Depending on the presence or absence of pacing artifact, the potential problems identifiable 
on an ECG can generally be assigned to three categories: 1) pacing artifact present with 
failure to capture, 2) pacing artifact absent with failure to pace, 3) pacing artifact present 
with failure to sense. 
2.1 Pacing artifact present with failure to capture 
To differentiate between different categories of the pacing system malfunctions, it is 
essential to identify the pacing artifact. This can be done easily in unipolar system with large 
pacing artifact. However, it can problematic in dual-chamber devices with diminutive 
pacing artifact. There are two important issues related to the pacing artifact that can cause 
great difficulty in differential diagnosis of pacing system malfunction.  Some ECG recording 
systems, such as holter monitoring and in-hospital monitoring units, contain special filter to 
eliminate baseline noise (Sheffield et al, 1985).These filters can markedly reduce the size of 
pacing artifact in the unipolar pacing system and effectively erase the pacing stimuli in the 
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bipolar system. In these situations, recording of the multiple simultaneous or sequential 
ECG leads with older analog ECG machines would be highly helpful. In addition, newer 
recording systems (e.g. telemetry system and holter recorder) have unique algorithms for 
pacemaker pulse detection that generate a discrete artifact in response to any high-
frequency signal. Therefore, even nonpacemaker signals may be displayed as pacing artifact. 
Electromagnetic interference, loose ECG electrode connections, and subthreshold pulses 
(minute ventilation sensors) are examples of nonpacemaker signals.  
The causes of failure to capture with pacing artifact present are summarized in Table 1. The 
onset of malfunction in relation to implantation of pacing system can provide valuable data 
to identification of the cause. If failure to capture occurred shortly (hours or days) after 
implant, the most likely diagnosis is lead dislodgment or perforation. Loss of capture weeks 
to months after implantation is most probably due to lead maturation process. Currently, 
this problem is rarely seen because of routine use of the steroid-eluting electrodes. This 
malfunction occurs between 2 to 6 weeks after implantation. If loss of capture of capture 
occurs several months to years after implantation, structural injury in the lead insulation or 
conductor should be suspected. Other less common causes in this period are exit block, 
metabolic abnormalities, pharmacological agents, misprogramming, and battery depletion.    
Lead dislodgment is accompanied by a change in the paced QRS morphology and/or the lead 
position in repeat chest x-rays. A change in the paced QRS morphology is diagnostically 
useful when fusion with native QRS complexes is absent. Depending on presence or absence 
of a visible change in the lead position on a repeat chest x-ray, lead dislodgment can 
classified as “macro-dislodgment” or “micro-dislodgment”. Other distinguishing features 
are normal pacing impedance and elevated thresholds. Incidence of the lead dislodgment 
has markedly reduced with the introduction of active fixation leads. However, active lead 
implantation does not guarantee long-term lead stability (Furman et al, 1975). Correction of 
this malfunction requires surgical intervention. Before reoperation, the cause of dislodgment 
should be identified. An examination of anchoring sleeve for adequate fixation, looking for 
adequate amount of current-of-injury in the recorded electrograms at the implant time, and 
looking for proper lead slack on postimplant chest x-ray would be highly informative. In 
most cases, lead repositioning is enough but thrombus developed around the lead tip may 
effectively prevent the lead tip to be fixed at new position. The latter situation, lead 
dislodgement with no identifiable cause and repeated dislodgment after prior lead 
repositioning requires new active lead implantation. Lead perforation usually occurs at the 
time of implant or within the first 24 hours (Aggarwal et al, 1995), although this 
complication has been reported up to 10 months after the device implantation (Haghjoo, 
2010). In addition to loss of capture, perforation manifests itself by lead migration to 
pericardial, pleural, or peritoneal space. Lead perforation can be confirmed by the negative 
current of injury at implant. Lead maturation is an inflammatory reaction that is produced 
following lead tip contact with endocardium (Furman et al, 1979; Furman et al, 1977). Local 
tissue swelling displaces the electrode tip from excitable myocardium and, consequently, 
increases the capture threshold. Although incidence of this problem was significantly 
reduced in steroid-eluting leads (Mond et al, 1988; Kein et al, 1990), a significant rise in 
threshold may occur despite the introduction of steroid-eluting leads and other innovation 
in lead design (Ellenbogen et al, 1999). This process occurs between 2 to 6 weeks after 
implantation. To minimize the probability of noncapture, a high output setting is 
recommended during this period. Any threshold rise after this period is considered to be in 
the chronic phase of lead maturation. If the threshold rise resulted in noncapture, it is 
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referred to as exit block (Sheppard et al, 1991; Davies & Sowton, 1966). Acute and chronic 
phase of lead maturation are not associated with a change in paced QRS morphology or lead 
location in chest x-ray. Acute threshold rise occasionally responds to systemic steroids. A 
regimen of prednisone, 60 mg (1 mg/kg) per day, is found to be effective in one-half of the 
patients (Levine, 2005). Exit block does not respond to systemic steroids and require lead 
repositioning or new lead implantation. 
 
Lead dislodgment 
Micro-dislodgment 
Macro-dislodgment 
Perforation 
Lead maturation process 
Early inflammation 
Late fibrosis- exit block 
Mechanical lead injury 
Insulation failure 
Conductor fracture 
Iatrogenic malfunctions 
Loose setscrew 
Misprogramming 
Elevated pacing thresholds 
Metabolic abnormalities 
Electrolyte disturbances 
Myocardial infarction 
Cardiomyopathy 
Pharmacological agents 
Pseudomalfunctions 
Table 1. Causes of failure to capture with pacing artifact present 
Lead insulation failure is mainly due to extrinsic forces exerted to the lead either at or 
following implantation. Insulation damage has reported both in silicone- and polyurethane-
coated leads (Kertes et al, 1983). Excessively tight suture on the anchoring sleeve, lead 
passage between clavicle and first rib, and abrasion between overlapping coils or between 
leads and housing of the pulse generator are three common causes of the insulation defect in 
clinical practice (Dunlap et al, 1983; Magney et al. 1993). ECG with an insulation failure 
involving a unipolar lead will show a decrease in amplitude of pacing artifact. An insulation 
damage involving outer insulation of a coaxial bipolar lead will show an increase in the 
amplitude of the pacing artifact (unipolarization). Failure of the internal insulation of a 
coaxial bipolar lead will results in a decrease in the amplitude of pacing artifact. This is best 
identified with an analog ECG recording system. Chest x-ray is normal in the patients with 
insulation failure because insulation material is radiolucent. Another specific feature of 
insulation defect is reduced lead impedance. 
Lead conductor fracture is the most common cause of an open circuit. Although the clinician 
might expect that fracture of a lead would result in the absence of any visible pacing artifact, 
this is frequently not the case. This occurs because the current passes across the gap in the 
conductor coil though the fluid in the lead with high resistance. In such circumstances, 
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energy reaching the heart is subthreshold with no capture, but a stimulus will be present. 
The ECG with an intermittent conductor fracture may show a varying amplitude artifact if 
recorded with an analog machine. Lead fracture is associated with infinitely high lead 
impedance if the insulation remains intact. However, total lead transsection (concomitant 
conductor fracture and insulation defect) may show normal or minimally elevated 
impedance. Chest x-ray may show conductor fracture (figure 1). In contrast to the unipolar 
lead, diagnosis of the conductor fracture is very difficult in a coaxial bipolar lead unless 
there is total disruption of both conductors at the same place. Reprogramming to unipolar 
mode is a temporary measure in partial fracture of bipolar lead. In pacemaker-dependent 
patients with complete lead transsection, temporary pacemaker implantation is necessary 
before definitive management. Definitive treatment of conductor fracture is lead 
replacement. 
 
 
Fig. 1. This chest x-ray illustrates a typical example of conductor fracture with intact 
insulation. Conductor fracture occurred near to the fixation sleeve.  
Loose set screw usually presents with failure to output due to complete disconnection of the 
lead pin and the connector. Sometimes, minimal contact between the pin and the connector 
may permit the transmission of the electrical current, but delivered energy is not enough to 
capture the paced chamber. This problem is produced because of the inadequate tightening 
of the lead pin within the connector block. The presence of air or fluid within the connector 
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can produce similar clinical picture. ECG usually may show a decrease in the amplitude of 
the pacing artifact. Chest x-ray clearly shows the displacement of the terminal pin out of the 
head of pacemaker. Reoperation with pin reconnection is necessary to correct these 
malfunctions.   
Battery depletion manifests several years after device implantation. Pacemaker-dependency is 
major determinant of the battery longevity. Although modern pacemakers attempt to 
maintain the programmed values until the battery is depleted, actual output will fall below 
the capture threshold and resulting in the loss of capture. ECG and chest x-ray show no 
abnormalities. Pacing threshold is increased as measured via depleted generator but is 
normal through the pacing system analyzer. Definitive management requires the generator 
replacement. 
Late rise in the pacing threshold may also occur secondary to the myocardial infarction, 
cardiomyopathy, metabolic abnormalities, and pharmacologic agents (Schlesinger et al, 1980; 
Hughes, et al, 1975; Preston & Judge 1969; Guarnieri et al, 1988). Any severe electrolyte or 
metabolic abnormalities can increase pacing threshold. These abnormalities include acidosis, 
alkalosis, hypoxemia, hypercarbia, hyperkalemia, hyperglycemia, and hypothyroidism. In 
addition, threshold rise and noncapture may be due to some pharmacological agents such as 
bretylium, class Ic antiarrhythmic drugs, sotalol, and mineralocorticoids. Myocardial 
infarction and cardiomyopathy can cause noncapture by producing nonexcitable tissue near 
the lead tip. Increasing the programmed output, correcting the cause, and the lead 
repositioning are the therapeutic options in these situations. 
2.2 Pacing artifact absent with failure to pace 
In this category of pacing system malfunction, the clinician must be certain that a 
malfunction truly exists before taking any corrective measure. Already diminutive pacing 
artifact of the bipolar pacing may be further obscured by being isoelectric in a given lead. 
New pacemaker algorithms for minimal ventricular pacing may also present with absence 
of the pacing artifact. Similarly, hysteresis and sleep function can mimic this malfunction. 
Differential diagnosis of pacing artifact present with failure to pace is listed in Table 2. 
Oversensing is the most common cause of intermittent pauses without pacing artifact.  
 
Oversensing 
Physiological signals- T-wave, myopotential 
Nonphysiologic signals- Electromagnetic interference 
Nonphysiologic signals- Make-break signals 
Open circuit 
Conductor fracture 
Loose set screw 
Insulation failure 
Battery depletion 
Pulse generator component malfunction 
Pseudomalfunctions 
Sleep function 
Hysteresis 
Algorithms for minimizing ventricular pacing 
Table 2. Causes of failure to pace 
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Oversensing is the sensing of a physiologically inappropriate or nonphysiologic signal. 
Oversensing is more common in the unipolar pacing. T-waves and myopotentials are major 
sources of the physiologically inappropriate signals. Myopotential oversensing either 
inhibits the ventricular output in the ventricular channel or triggers ventricular output when 
sensed on the atrial channel of a DDD pacemaker. T-wave oversensing can similarly 
produce long asystole in pacemaker-dependent patients. If the native signal is sufficiently 
large, reducing the ventricular sensitivity can easily correct this abnormality.   
Nonphysiologic electrical signals may also cause oversensing. The potential sources of 
electromagnetic interference (EMI) are electrocautery, electrolysis, radiofrequency (RF) 
ablation, cardioversion, defibrillation, lithotripsy, magnetic resonance scanner, positron 
emission tomographic scanner, high voltage power line, cellular and cordless phone, 
transcutaneous electrical nerve stimulation, and radiotransmission (AM and FM). Other 
nonphysiologic source of oversensing is make-break signals. If of sufficient amplitude, these 
signals can cause significant oversensing and long pauses. The most common sources of 
make-break signals are loose set-screw, partial conductor fracture, failure of the internal 
insulation of bipolar lead, loose active fixation screw, and interaction between active and 
abandoned leads. Diagnosis of the oversensing can be confirmed by applying magnet or 
programming to asynchronous mode. The oversensing-related pauses are relieved by 
before-mentioned maneuvers. The definitive treatment differs depending on the sources of 
oversensing. The lead problems require lead replacement, or repositioning, or correction of 
the loose connection. Oversensing related to the physiological signals can be treated by 
reprogramming or lead repositioning. EMI-related oversensing needs avoidance from EMI 
sources. 
Open circuit secondary to conductor fracture or loose set screw are second most common cause of 
pauses associated with absence of the pacing artifact. As it was mentioned previously, open 
circuit usually present with loss of capture in the absence of pacing artifact. Measured data 
telemetry will show infinitely high pacing impedance. Chest x-ray can be diagnostic in 
unipolar lead but conductor fracture is difficult to detect in case of a bipolar lead. Magnet 
application has no effect on pauses associated with open circuit. Definitive treatment is the 
lead replacement or tightening of the pin within the header. 
Lead insulation failure can cause failure to capture in the absence of pacing artifact mainly 
because of oversensing. Again, malfunction persists after magnet application. 
Reprogramming to unipolar mode can temporarily correct the malfunction until definitive 
treatment is done.  
Pulse generator malfunction is the least common cause of the pacing system malfunction. 
This malfunction does not respond to magnet application. Pacemaker interrogation shows 
inconsistent measurements or inaccessible data. Pulse generator replacement is the only 
effective treatment. 
2.3 Pacing artifact present with failure to sense 
A proper sensing require good quality signal with adequate amplitude and slew rate. 
Apparently high amplitude signal may not be appropriately sensed because of the slow 
slew rate (Furman et al, 1977). Undersensing is characterized by the inappropriate pacing 
because of underdetection of the intrinsic signals (figure 2). The etiologies of the 
undersensing are listed in Table 3. As in failure to capture, onset of the undersensing in 
relation to implantation time may direct the clinician to the correct diagnosis. Early-onset 
undersensing is most probably due to lead dislodgment or lead perforation. Late-onset 
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undersensing is frequently caused by mechanical lead problems (insulation failure and partial 
open circuit) or programming errors. Occasionally, they are attributable to a change in the 
morphology of the intrinsic cardiac signal. 
In addition to failure to capture, the lead dislodgment is frequently associated with 
undersensing.  In this circumstance, displaced lead will record a signal different from and 
usually smaller than that recorded at implant. Perforated lead similarly records a smaller 
signal. Therefore, sensing failure will occur in both situations. Definitive management is the 
lead replacement.   
Lead insulation failure can be associated with sensing failure due to attenuation of the 
incoming signal. Other corroborating features are increased capture threshold, decreased 
pacing impedance, increased battery drain, and reduced amplitude of the pacing artifact. 
Curative treatment will require lead replacement or repair.  
 
 
Fig. 2. This tracing shows inappropriate atrial pacing because intrinsic depolarization is not 
seen by the pacemaker. 
 
Lead dislodgment 
Micro-dislodgment 
Macro-dislodgment 
Perforation 
Lead maturation process 
Mechanical lead injury 
Insulation failure 
Partial open circuit 
Battery depletion 
Elevated pacing thresholds 
Metabolic abnormalities 
Electrolyte disturbances 
Myocardial infarction 
Cardiomyopathy 
Pharmacological agents 
Pseudomalfunctions 
Asynchronous mode 
Triggered mode 
DVI mode 
Safety pacing 
Table 3. Causes of sensing failure 
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Partial open circuit is another cause of the undersensing. If the two ends of the conductor are 
making any contact at all, resistance to incoming signal will reduce the amplitude of the 
filtered signal and undersensing will occur. Infinitely high impedance is an important 
diagnostic feature. Chest x-ray is also diagnostic in some cases. Correction of this 
malfunction requires lead replacement or reconnection of the lead pin within the connector 
block. 
Change in the native signal amplitude occurs secondary to myocardial infarction, 
cardiomyopathy, metabolic abnormalities, and some pharmacologic agents. 
As the pulse generator begins to become depleted, intermittent or persistent undersensing may 
occur. Stuck reed switch is another rare cause of the undersensing. Placing magnet over the 
pacemaker or triggered mode are other causes of the failure to sense. In pacemakers using 
impedance plethysmography as a rate modulation sensor, removal of generator out of the pocket 
will result in the asynchronous pacing in response to a lot of electrical noise.  Definitive 
treatment of the undersensing depends on the underlying cause. 
3. Dual-chamber pacing system malfunction 
Dual-chamber pacing system malfunctions can be categorized into two groups: 1) general 
dual-chamber pacing system malfunctions; 2) specific dual-chamber pacing system 
malfunctions. 
3.1 General dual-chamber pacing system malfunctions 
All abnormalities previously discussed in the section of the single-chamber pacing system 
malfunctions can occur with either channel of the dual-chamber pacemakers. However, 
malfunctions easily detected in single-chamber pacemakers may be very difficult to 
diagnose in dual-chamber devices. For example, detection of the ventricular loss of capture 
may be very challenging in the presence of normal atrioventricular (AV) conduction. In this 
situation, changing the AV interval can be very useful. Occasionally, it is not easy to detect 
atrial noncapture in the dual-chambers pacing systems. In this situation, programming to 
AAI mode or increasing AV interval will readily unmask the malfunction. Atrial 
undersensing may be difficult to recognize in the presence of an intact sinus node function. 
Oversensing in dual-chamber pacing systems can result in inappropriate inhibition or 
triggering depending on the channel on which oversensing occurs and the programmed 
pacing mode. Atrial channel oversensing will result in rapid ventricular pacing whereas 
oversensing in the ventricular channel will inhibit both atrial and ventricular channels. 
3.2 Specific dual-chamber pacing system malfunctions 
Crosstalk is the sensing of the far-field signal in the opposite chamber, causing the 
pacemaker to either inhibit or trigger an output depending on its design. Crosstalk can 
occur in any dual-chamber mode in which atrium is paced and the ventricle is sensed and 
paced (DVI, DDI, and DDD). In the presence of complete heart block, inhibition of the 
ventricular pacing can be life-threatening (Sweesy et al, 1988). Crosstalk is more difficult to 
detect in the presence of intact AV conduction. Several factors predispose the patients to 
crosstalk inhibition of the ventricular output: unipolar atrial and ventricular leads, high 
atrial output, high ventricular sensitivity, and short ventricular blanking and refractory 
periods. Crosstalk is diagnosed by the ventricular sensing in the absence of a QRS complex 
in the telemetered marker channels and corrected by the magnet application.  
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There are several preventive strategies to avoid the crosstalk or its sequel. Use of a bipolar 
lead with adequate amplitude and pulse width, proper ventricular sensitivity, use of the 
ventricular blanking period, and safety pacing are the main approaches to prevent the 
crosstalk (Batey et al, 1985; Barold & Belott, 1987).  
Pacemaker-mediated tachycardia (PMT) is characterized by the active participation of the 
pacemaker in the tachycardia (figure 3). There are several forms of PMT. Typical form of 
PMT is endless-loop tachycardia (ELT). ELT only occur in patients with P-synchronous 
dual-chamber pacing (DDD, VDD) and intact retrograde ventriculoatrial conduction. ELT is 
classically initiated by a PVC. If the PVARP has expired and retrograde P-wave is sensed, 
the sensed atrial event triggers the ventricular output. This setups a repetitive sequence of 
the sensed retrograde P-wave, triggering a ventricular output at the end of maximum 
tracking rate interval (Den Dulk et al, 1982). In addition to PVC, atrial undersensing, atrial 
oversensing, and atrial noncapture may initiate ELT. PVARP extension after a sensed 
ventricular event is the main defense against the ELT. If ELT is initiated, PVARP extension 
and withholding the ventricular output for one cycle are the major modalities to terminate 
ELT. Second form of PMT is secondary to tracking of atrial signals (atrial 
tachycardia/flutter/fibrillation) (figure 4) or oversensing on the atrial channel (Greenspan et 
al, 1984). This is not a pacemaker malfunction and terminated by applying magnet. Third 
form of PMT is called repetitive nonreentrant ventriculoatrial synchronous rhythm (Love, 
2007). Several factors predispose the patient to this kind of PMT. First, intact ventriculoatrial 
conduction is needed. Second, a sufficiently long PVARP should be programmed to avoid 
ELT induction. Third, a relatively rapid baseline rate is also required to render the atrial 
tissue refractory. In this condition, retrograde P-wave is not sensed (functional 
undersensing) allowing atrial escape interval to be completed and atrial pulse is delivered 
with no capture (functional noncapture). Then, the ventricular output is delivered at the end 
of the programmed AV interval. Therefore, this rhythm is characterized by ventricular 
pacing, atrial undersensing, and atrial noncapture in the presence of normally functioning 
dual-chamber DDDR or DDIR pacemakers (figure 5). To prevent this rhythm, a new 
algorithm called noncompetitive atrial pacing (NCAP) has been introduced. Other 
preventive strategies are providing short AV intervals at high rates or AAI pacing. 
 
 
 
Fig. 3. This tracing was recorded from a patient with dual-chamber pacemakers who presented 
with frequent palpitations. Pacemaker interrogation showed frequent episodes of 
pacemaker-mediated tachycardia initiated by a PVC and terminated by a P-wave falling 
within the PVARP. 
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Fig. 4. This figure is recorded from a patient with dual-chamber pacemaker and paroxysmal 
palpitations. Device interrogation showed tracking of the atrial signals during paroxysmal 
atrial tachycardias. 
 
 
 
Fig. 5. This figure shows a classical example of repetitive nonreentrant ventriculoatrial 
synchronous rhythm. This rhythm is characterized by ventricular pacing, atrial 
undersensing, and atrial noncapture in the presence of normally functioning dual-chamber 
pacemakers. 
4. Biventricular pacing system malfunction 
Biventricular pacing system malfunctions can be categorized into two groups: 1) general 
biventricular pacing system malfunctions; 2) specific biventricular pacing system 
malfunctions. 
4.1 General biventricular pacing system malfunction 
This category includes all abnormalities previously discussed in the section of single- and 
dual-chamber pacemakers. 
4.2 Specific biventricular pacing system malfunction 
As the left ventricular (LV) lead is not as secure as the right ventricular (RV) lead, LV lead 
dislodgment is more common than RV lead. However detection of noncapture in the LV 
lead is very difficult because of the intact RV pacing. Baseline ECG recording after implant 
would be highly useful in this regard. Therefore, LV lead noncapture mainly present with 
heart failure decompensation. 
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5. Pseudomalfunctions 
Pseudomalfunctions are defined as unexpected ECG findings that appear to result from 
pacemaker malfunction but that represent normal pacemaker function. Pseudomalfunctions 
should be ruled out as the cause(s) of an anomalous ECG strip before corrective measures 
are taken.  
Pseudomalfunctions may be classified into three categories: 1) rate change, 2) anomalous 
AV interval or refractory period, and 3) mode change.  
5.1 Rate change 
Rate changes in the presence of normal pacemaker function may occur secondary to magnet 
operation, timing variations (A-A vs. V-V), upper rate behavior (wenckebach or 2:1 block), 
electrical reset, PMT intervention, and rate response. Furthermore, hysteresis, rate drop 
response, mode switching, and sleep function have varying degrees of impact on the rate. 
Magnet operation varies within different products and from manufacturer to manufacturer, 
but will usually involve a rate change (increase or decrease depending on manufacturer) 
when the magnet is applied. Wenckebach block has the characteristic Wenckebach pattern of 
the PR interval gradually extending beat-to-beat until a ventricular beat is dropped. 
Wenckebach block occurs when the intrinsic atrial rate begins to exceed the upper rate limit. 
The ventricular response to the intrinsic atrial event cannot exceed the upper rate limit, so 
the AV interval is lengthened until the upper rate expires and a ventricular pace can be 
delivered. An atrial sensed event eventually falls into the refractory period and is not seen, 
and therefore not followed, by a ventricular pace. Two to one block is characterized by atrial 
rates that occur at intervals less than the total atrial refractory period (TARP). Every other P-
wave falls into the refractory period and is therefore not preceded by a paced ventricular 
event. Patients who experience 2:1 block, particularly those who are active at the time the 
event occurs, will feel the precipitous drop in rate, which is cut in half. Electrical reset may 
occur secondary to exposure to EMI such as electrocautery, defibrillation, etc. These EMI 
sources can cause both rate and mode changes (back-up mode). As it was mentioned 
previously, PMT intervention is designed to terminate PMT. In Medtronic pacemakers, when 
PMT intervention is turned ON, the PVARP will be forced to 400 msec after the ninth paced 
ventricular event. By extending the PVARP, the intent is to interrupt atrial tracking for one 
cycle and break the PMT. After an intervention, PMT Intervention is automatically 
suspended for 90 seconds before the pacemaker can monitor for a PMT again. In rate 
responsive pacemakers, physical activity will cause an increase in the pacing rate. However, 
some patients may experience “false positive” increases in rate from their sensors. In the 
case of a piezoelectric crystal, the pacemaker may begin pacing at a faster rate if, for 
example, the patient is either lying on the side that the pacemaker is implanted on or 
experiencing a bumpy car ride. Similarly, minute ventilation sensors measure the change in 
respiration rate and tidal volume. If a patient experiences rapid respiration resulting from a 
cause other than exercise (e.g., hyperventilation), the pacemaker may begin pacing at a 
faster rate. Hysteresis provides the capability to maintain the patient’s intrinsic heart rhythm 
as long as possible, while providing back-up pacing if the intrinsic rhythm falls below the 
hysteresis rate. Because hysteresis exhibits longer intervals after sensed events, it may be 
perceived as oversensing. Rate drop response will exhibit pacing at high rates if the detection 
criteria are met. Rate drop response therapy prevents a precipitous decrease in the rate in 
patients experiencing cardioinhibitory neurally-mediated syncope. Mode switching is used to 
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prevent the tracking of the atrial signals in paroxysmal atrial tachycardia, atrial flutter, or 
atrial fibrillation in the DDD(R) and VDD(R) modes. Mode switching is associated both with 
rate slowing and mode change to DDI(R) or VVI(R). Sleep function is designed to provide a 
slower rate while patient sleeping. 
5.2 Anomalous AV interval and refractory period  
AV interval or refractory periods may appear anomalous due to safety pacing, blanking, 
rate-adaptive AV delay, sensor-varied PVARP, PVC response, and NCAP. Safety pacing is 
designed to prevent inhibition due to crosstalk. This algorithm delivers a ventricular output 
110 ms after an atrial paced event. Therefore, safety pacing is manifested as abbreviated AV 
interval. Blanking is the first portion of the refractory period during which the pacemaker is 
“blind” to any activity. Blanking is designed to prevent multiple detection of a single paced 
or sensed event by the sense amplifier. However, if the blanking period is too long, it may 
not sense an event and cause inappropriate pacing. Rate-adaptive AV delay is designed to 
mimic the intrinsic response to increasing heart rate. In a normal heart, PR intervals 
decrease as the heart rate increases. Conversely, as the heart rate decreases, PR intervals 
increase. The rate-adaptive AV delay can be programmed to mimic the normal physiologic 
response of the PR interval to increasing heart rates. When sensor-varied PVARP is enabled, 
the duration of the PVARP will shorten as the rate increases. PVC response designates a PVC 
as a ventricular sensed event following a ventricular event with no intervening atrial event. 
When a PVC is detected, and PVC response is programmed ON, the PVARP is extended in 
order to avoid sensing the retrograde P-wave that could occur as a result of the PVC. 
Pacemaker-defined PVC will initiate a V-A interval. This extended PVARP (if PVC response 
is ON) and subsequent resetting of the timing interval may appear anomalous on an ECG. 
NCAP can be used in an effort to prevent atrial pacing from occurring too close to a 
refractory sensed event. If NCAP is programmed ON, the scheduled atrial output will be 
delayed until at least 300 msec has elapsed since the refractory sensed P wave occurred. 
PAV interval may then be shortened to maintain a stable ventricular rate. 
5.3 Mode change 
Change in pacing mode may occur secondary to electrical reset, mode switching, and noise 
revision. Electrical reset and mode switching have been described in the section of mode 
change. The portion of the refractory period after the blanking period ends is commonly 
called the “noise sampling period.” A sensed event in the noise sampling period will initiate 
a new refractory period and blanking period. Continuous refractory sensing is called noise 
reversion and will cause pacing to occur at the sensor-indicated rate for rate-responsive 
modes and cause pacing to occur at the lower rate for non-rate responsive modes. 
6. Conclusions 
Pacing system malfunctions can be secondary to the pacemaker circuitry failure or to the 
lead dysfunction. Although primary malfunctions of the pulse generators do occur, they are 
least common cause of the malfunctions related to the pacing system. More commonly, 
problems are related to the damaged leads or primary abnormality at electrode-myocardial 
interface. Not uncommonly what appears to be pacemaker malfunction may actually 
represent normal functioning of the pacemaker.  
www.intechopen.com
Pacing System Malfunction: Evaluation and Troubleshooting 
 
379 
7. References 
Aggarwal, R.; Connelly, D.; Ray, S.; Ball, J. & Charles, R. (1995). Early complications of 
permanent pacemaker implantation: no difference between dual and single 
chamber systems. Br Heart J, 73, 6, (June 1995), 571-575, 1355-6037. 
Barold, S. & Belott, P. (1987). Behavior of the ventricular triggering period of DDD 
pacemakers. Pacing Clin Electrophysiol, 10, 6, (November 1987), 1237-1252, 0147-
8389. 
Combs, W.; Reynolds, D.; Sharma, A. & Bennett, T. (1989). Crosstalk in bipolar pacemakers. 
Pacing Clin Electrophysiol, 12, 10, (October 1989), 1613-1621, 0147-8389. 
Davies, J. & Sowton, E. (1966). Electrical threshold of the human heart. Br Heart J, 28, 2, 
(March 1966), 231-239, 1355-6037. 
Dulk, K.; Lindemans, F.; Bar, F. & Wellens, H. (1982). Pacemaker-related tachycardias. 
Pacing Clin Electrophysiol, 5, 4, (July 1982), 476-485, 0147-8389. 
Dunlap, T.; Popak, K. & Sorkin, R. (1983). Radiographic pseudofracture of the Medtronic 
bipolar polyurethane pacing lead. Am Heart J, 106, 1, (July 1983), 167-168, 0002-8703. 
Ellenbogen, K.; Wood, M.; Gilligan, D.; Zmijewski, M. & Mans, D. (1999). Steroid eluting 
high impedance pacing leads decrease short- and long-term current drain: results 
from a multicenter clinical trial. CapZure Z investigators. Pacing Clin Electrophysiol, 
22, 1, (January 199), 39-48, 0147-8389. 
Furman, S.; Hurzeler, P. & De Caprio, V. (1977). Cardiac pacing and pacemakers III: Sensing 
the cardiac electrogram. Am Heart J, 93, 6, (June 1977), 794-801, 0002-8703. 
Furman, S.; Hurzeler, P. & Mehra, R. (1977). Cardiac pacing and pacemakers IV. The 
threshold of cardiac stimulation. Am Heart J, 94, 1, (July 1977), 115-124, 0002-8703. 
Furman, S.; Pannizzo, F. & Campo, I. (1979). Comparison of active and passive adhering 
leads for endocardial pacing. Pacing Clin Electrophysiol, 2, 4, (July 1979), 417-427, 
0147-8389. 
Greenspan, A.; Greenberg, R. & Frank, W. (1984). Tracking of atrial flutter by DDD pacing, 
another form of pacemaker-mediated tachycardia. Pacing Clin Electrophysiol, 7, 6, 
(November 1984), 955-960, 0147-8389. 
Guarnieri, T.; Datorre, S.; Bondke, H.; Brinker, J.; Myers, S. & Levine, J. (1988). Increased 
pacing threshold after an automatic defibrillatory shock in dogs: effects of class I 
and class II antiarrhythmic agents. Pacing Clin Electrophysiol, 11, 9, (September 
1988), 1324-1330, 0147-8389. 
Haghjoo, M.; Alizadeh, A.; Fazelifar, A.; Hajahmadi, M. & Sadr-Ameli M. (2010). Delayed 
cardiac perforation by one small body diameter defibrillator lead. J Electrocardiol, 
43, 1o, (January-February 2010), 71-73, 0022-0736.  
Hughes, J.; Tyers, G. & Torman, H. (1975). Effects of acid-base imbalance on myocardial 
pacing thresholds. J Thorac Cardiovasc Surg, 69, 5, (May 1975), 743-746, 0022-5223. 
Kein, H.; Steinberger, J. & Knack, W. (1990). Stimulation characteristics of a steroid-eluting 
electrode compared with three conventional electrodes. Pacing Clin Electrophysiol, 
13, 2, (February 1990), 134-137, 0147-8389. 
Kertes, P.; Mond, H.; Sloman, G.; Vohra, J. & Hunt, D. (1983).Comparison of lead 
complications with polyurethane tined, silicone rubber tined, and wedge tip leads: 
clinical experience with 822 ventricular endocardial lads. Pacing Clin Electrophysiol, 
6, 5, (September 1983), 957-962, 0147-8389. 
www.intechopen.com
 Modern Pacemakers - Present and Future 
 
380 
Levine, P. (2005). Evaluation and management of pacing system malfunctions, In: Cardiac 
pacing and ICDs, Ellenbogen, K. & Wood, M. (4th Ed.), p.329, Blackwell publishing, 
978-1-4051-0447-0, Massachusetts. 
Preston, T. & Judge, R. (1969). Alteration of pacemaker threshold by drug and physiologic 
factors. Ann N Y Acad Sci, 167, No, (October 1969), 686-692, 0077-8923. 
Love, C. (2007). Pacemaker troubleshooting and follow-up, In: Clinical cardiac pacing, 
defibrillation, and resynchronization therapy, Ellenbogen, K.; Kay, G.; Lau, C. & 
Wilkoff, B. (3rd Ed.), pp.1054-1055, WB Saunders, 978-1-4160-2536-8, Philadelphia. 
Mond, H.; Strokes, K.; Helland, J.; Grigg, L.; Kertes, P; Pate, B. & Hunt D. (1988). The porous 
titanium steroid-eluting electrode: a double-blind study assessing the stimulation 
threshold effects of steroid. Pacing Clin Electrophysiol, 11, 2, (February 1988), 214-
219, 0147-8389. 
Magney, J.; Flynn, D.; Parsons, J.; Staplin, D; Chin-Purcel, M.; Milstein, S. & Hunter, D. 
(1993). Anatomical mechanisms explaining damage to pacing leads, defibrillator 
leads and failure of central venous catheters adjacent to the sternoclavicular joint. 
Pacing Clin Electrophysiol, 16, 3, (March 1993), 445-457, 0147-8389. 
Schlesinger, Z.; Rosenberg, T.; Stryjer, D. & Gilboa, Y. (1980). Exit block in myxedema, 
treated effectively with thyroid hormone therapy. Pacing Clin Electrophysiol, 3, 6, 
(November 1980), 737-739, 0147-8389.   
Sheffield, L.; Berson, A.; Bragg-Remschel, D.; Gillette, P.; Hermes, R.; Hinkle, L.; Kennedy, 
H.; Mirvis, D. & Oliver, C. (1985). AHA special report: recommendation for 
standards of instrumentation and practice in the use of ambulatory 
electrocardiography. Circulation, 71, 3, (March 1985), 626A-636A, 0009-7322. 
Shepard, R.; Kim, J.; Colvin, E.; Slabaugh, J.; Epstein, A. & Bargeron Jr, L. (1991). Pacing 
threshold spikes months and years after implant. Pacing Clin Electrophysiol, 14, 11, 
(November 1991), 1835-1841, 0147-8389. 
Sweesy, M.; Batey, R. & Forney, RC. (1988). Crosstalk during bipolar pacing. Pacing Clin 
Electrophysiol, 11, 11, (November 1988), 1512-1516, 0147-8389. 
 
 
 
 
www.intechopen.com
Modern Pacemakers - Present and Future
Edited by Prof. Mithilesh R Das
ISBN 978-953-307-214-2
Hard cover, 610 pages
Publisher InTech
Published online 14, February, 2011
Published in print edition February, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The book focuses upon clinical as well as engineering aspects of modern cardiac pacemakers. Modern
pacemaker functions, implant techniques, various complications related to implant and complications during
follow-up are covered. The issue of interaction between magnetic resonance imaging and pacemakers are
well discussed. Chapters are also included discussing the role of pacemakers in congenital and acquired
conduction disease. Apart from pacing for bradycardia, the role of pacemakers in cardiac resynchronization
therapy has been an important aspect of management of advanced heart failure. The book provides an
excellent overview of implantation techniques as well as benefits and limitations of cardiac resynchronization
therapy. Pacemaker follow-up with remote monitoring is getting more and more acceptance in clinical practice;
therefore, chapters related to various aspects of remote monitoring are also incorporated in the book. The
current aspect of cardiac pacemaker physiology and role of cardiac ion channels, as well as the present and
future of biopacemakers are included to glimpse into the future management of conductions system diseases.
We have also included chapters regarding gut pacemakers as well as pacemaker mechanisms of neural
networks. Therefore, the book covers the entire spectrum of modern pacemaker therapy including implant
techniques, device related complications, interactions, limitations, and benefits (including the role of pacing
role in heart failure), as well as future prospects of cardiac pacing.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Majid Haghjoo (2011). Pacing System Malfunction: Evaluation and Troubleshooting, Modern Pacemakers -
Present and Future, Prof. Mithilesh R Das (Ed.), ISBN: 978-953-307-214-2, InTech, Available from:
http://www.intechopen.com/books/modern-pacemakers-present-and-future/pacing-system-malfunction-
evaluation-and-troubleshooting
www.intechopen.com
www.intechopen.com
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
